PreprintCited by 16CRISPR and Genetic EngineeringRNA regulation and diseaseBacterial Genetics and Biotechnology

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Structure-guided engineering of type I-F CASTs for targeted gene insertion in human cells

Open access

Preprint — published as 10.1038/s41467-025-63164-0

Abstract

Conventional genome editing tools rely on DNA double-strand breaks (DSBs) and host recombination proteins to achieve large insertions, resulting in a heterogeneous mixture of undesirable editing outcomes. We recently leveraged a type I-F CRISPR-associated transposase (CAST) from the Pseudoalteromonas Tn 7016 transposon ( Pse CAST) for DSB-free, RNA-guided DNA integration in human cells, taking advantage of its programmability and large payload capacity. Pse CAST is the only characterized CAST system that has achieved human genomic DNA insertions, but multiple lines of evidence suggest that DNA binding may be a critical bottleneck that limits high-efficiency activity. Here we report structural determinants of target DNA recognition by the Pse CAST QCascade complex using single-particle cryogenic electron microscopy (cryoEM), which revealed novel subtype-specific interactions and RNA-DNA heteroduplex features. By combining our structural data with target DNA library screens and rationally engineered protein mutations, we uncovered CAST variants that exhibit increased integration efficiency and modified PAM stringency. Structure predictions of key interfaces in the transpososome holoenzyme also revealed opportunities for the design of hybrid CASTs, which we leveraged to build chimeric systems that combine high-activity DNA binding and DNA integration modules. Collectively, our work provides unique structural insights into type I-F CAST systems while showcasing multiple diverse strategies to investigate and engineer new RNA-guided transposase architectures for human genome editing applications.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/2024.09.19.613948

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 61

  1. 10.1038/nrm2351 · DOI · Paper page
  2. 10.1146/annurev-genet-051710-150955 · DOI · Paper page
  3. 2018, Modulating DNA Repair Pathways to Improve Precision Genome Engineering, ACS Chem. Biol, 13, 389, 10.1021/acschembio.7b00777 · DOI
  4. 10.7554/elife.51539 · DOI
  5. 10.1016/j.cell.2020.10.038 · DOI · Paper page
  6. 10.1038/s41586-018-0380-z · DOI · Paper page
  7. Kosicki, M. , Tomberg, K. & Bradley, A . Repair of double-strand breaks induced by CRISPR– Cas9 leads to large deletions and complex rearrangements. Nat. Biotechnol. 36, (2018). · DOI · Paper page
  8. 2021, Chromothripsis as an on-target consequence of CRISPR–Cas9 genome editing, Nat. Genet, 53, 895, 10.1038/s41588-021-00838-7 · DOI · Paper page
  9. 2022, Frequent aneuploidy in primary human T cells after CRISPR–Cas9 cleavage, Nat. Biotechnol, 40, 1807, 10.1038/s41587-022-01377-0 · DOI
  10. 10.1016/J.CELL.2023.08.041 · DOI
  11. 10.1038/nature17946 · DOI · Paper page
  12. 10.1038/nbt.3803 · DOI · Paper page
  13. 10.1038/nature24644 · DOI · Paper page
  14. 10.1038/s41586-019-1711-4 · DOI · Paper page
  15. 10.1038/s41586-019-1323-z · DOI
  16. 2019, RNA-guided DNA insertion with CRISPR-associated transposases, Science, 364, 48
  17. 2023, Targeted DNA integration in human cells without double-strand breaks using CRISPR-associated transposases, Nat. Biotechnol, 42, 87
  18. 2021, Dual modes of CRISPR-associated transposon homing, Cell, 184, 2441, 10.1016/j.cell.2021.03.006 · DOI
  19. 2023, Discovery and characterization of novel type I-D CRISPR-guided transposons identified among diverse Tn7-like elements in cyanobacteria, 51, 765
  20. 10.1038/s41586-019-1849-0 · DOI
  21. 2023, Molecular mechanism for Tn7-like transposon recruitment by a type I-B CRISPR effector, Cell, 186, 4204, 10.1016/j.cell.2023.07.010 · DOI
  22. 2023, Multiple adaptations underly co-option of a CRISPR surveillance complex for RNA-guided DNA transposition, Mol. Cell, 83, 1827, 10.1016/j.molcel.2023.05.005 · DOI
  23. 2019, CRISPR–Cas in mobile genetic elements: counter-defence and beyond, Nat. Rev. Microbiol, 17, 513, 10.1038/s41579-019-0204-7 · DOI
  24. 10.1186/s13100-021-00236-0 · DOI
  25. 2022, Structural basis for the assembly of the type V CRISPR-associated transposon complex, Cell, 185, 4999, 10.1016/j.cell.2022.11.009 · DOI
  26. 10.1016/j.molcel.2021.12.021 · DOI
  27. 10.1093/nar/gkac985 · DOI
  28. Rybarski, J. R. , Hu, K. , Hill, A. M. , Wilke, C. O. & Finkelstein, I. J . Metagenomic discovery of CRISPR-associated transposons. Proc. Natl. Acad. Sci. U. S. A. 118, (2021). · DOI
  29. 10.1016/j.cell.2020.11.005 · DOI
  30. 2023, Novel molecular requirements for CRISPR RNA-guided transposition, Nucleic Acids Res, 51, 4519, 10.1093/nar/gkad270 · DOI
  31. 2021, CRISPR RNA-guided integrases for high-efficiency, multiplexed bacterial genome engineering, Nat. Biotechnol, 39, 480, 10.1038/s41587-020-00745-y · DOI
  32. 2022, Species- and site-specific genome editing in complex bacterial communities, Nat. Microbiol, 7, 34
  33. George, J. T. et al. Mechanism of target site selection by type V-K CRISPR-associated transposases. Science 382, (2023). · DOI
  34. 2020, Response to Comment on “RNA-guided DNA insertion with CRISPR-associated transposases”, Science, 368, 1
  35. 10.1038/s41587-022-01574-x · DOI
  36. 10.1126/science.abi8976 · DOI
  37. 10.1073/pnas.2110877119 · DOI
  38. 10.1038/s41586-021-04030-z · DOI
  39. 2023, Structures of the holo CRISPR RNA-guided transposon integration complex, Nature, 613, 775, 10.1038/s41586-022-05573-5 · DOI · Paper page
  40. 10.1038/s41586-022-05059-4 · DOI
  41. 10.1038/s41422-019-0272-2 · DOI
  42. 10.1038/s41422-020-0274-0 · DOI
  43. 10.1038/s41422-019-0268-y · DOI
  44. 2021, CryoDRGN: reconstruction of heterogeneous cryo-EM structures using neural networks, Nat. Methods, 18, 176, 10.1038/s41592-020-01049-4 · DOI
  45. 2020, CRISPR-Cas ‘non-Target’ Sites Inhibit On-Target Cutting Rates, CRISPR J, 3, 550, 10.1089/crispr.2020.0065 · DOI
  46. 10.1186/s12915-020-00857-6 · DOI
  47. 10.1016/j.molcel.2019.02.001 · DOI
  48. 10.1016/j.cell.2017.09.006 · DOI
  49. 10.1016/j.cell.2017.03.012 · DOI
  50. 10.1093/nar/gkh271 · DOI
  51. 10.1073/pnas.1011428107 · DOI
  52. 2020, The attachment of a DNA-binding Sso7d-like protein improves processivity and resistance to inhibitors of M-MuLV reverse transcriptase, FEBS Lett, 594, 4338, 10.1002/1873-3468.13934 · DOI
  53. 2022, Nature-inspired engineering of an artificial ligase enzyme by domain fusion, Nucleic Acids Res, 50, 11175, 10.1093/nar/gkac858 · DOI
  54. 10.1126/science.1256328 · DOI
  55. 10.1016/j.celrep.2017.11.110 · DOI
  56. Aldag, P. et al. Dynamic interplay between target search and recognition for a Type I CRISPR-Cas system. Nat. Commun. 14, (2023). · DOI
  57. 10.1016/j.cell.2013.02.022 · DOI · Paper page
  58. 10.1093/emboj/cdf347 · DOI
  59. 10.1038/s41586-024-07215-4 · DOI · Paper page
  60. 10.1038/srep37274 · DOI
  61. 10.1093/nar/28.14.2643 · DOI

Metadata

Authors
Lampe, G. D., Liang, A. R., Zhang, D. J., Fernández, I. S., & Sternberg, S. H.
Affiliations
  • Columbia University (US)
  • University of Copenhagen (DK)
  • Ikerbasque (ES)
  • Howard Hughes Medical Institute (US)
Corresponding author
  • Fernández, Israel S.
  • Sternberg, Samuel H.
Venue
Nature Communications
Publisher
openRxiv
Published
2024-09-19
Volume
16
Issue
1
Pages
7891-7891
ISSN
2041-1723 (ISSN-L)
OpenAlex
W4413473455
Cited by
16
References
1
Citations by year
2026: 10 · 2025: 6
FWCI
4.81
Type
journal article
Language
en
Open access
Locations
  • Nature Communications (publishedVersion, cc-by-nc-nd)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • DIGITAL.CSIC (Spanish National Research Council (CSIC)) (acceptedVersion, other-oa)
  • PubMed Central (submittedVersion, cc-by-nc-nd)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • U.S. Department of Health and Human Services (DP2HG011650)
  • St. Jude Children's Research Hospital
  • National Institutes of Health
  • Irving Medical Center, Columbia University
  • National Human Genome Research Institute (DP2HG011650, RM1HG009490)
  • National Institute of General Medical Sciences (U24GM129539)
  • National Institute of Allergy and Infectious Diseases (R21AI168976)
  • National Institute of Biomedical Imaging and Bioengineering (R01EB031935, R01EB027793)
  • Common Fund (U24 GM129539)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
Keywords
CRISPR-associated transposases, CAST, type I-F CRISPR-Cas, RNA-DNA heteroduplex, PAM recognition, structure-guided engineering, human genome editing

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review